Logo image of STG

SUNLANDS TECHNOLOGY- SP ADR (STG) Stock Fundamental Analysis

NYSE:STG - New York Stock Exchange, Inc. - US86740P2074 - ADR - Currency: USD

6.16  -0.43 (-6.53%)

After market: 6.8123 +0.65 (+10.59%)

Fundamental Rating

4

STG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. While STG has a great profitability rating, there are some minor concerns on its financial health. STG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year STG was profitable.
In multiple years STG reported negative net income over the last 5 years.
In the past 5 years STG reported 4 times negative operating cash flow.
STG Yearly Net Income VS EBIT VS OCF VS FCFSTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

With an excellent Return On Assets value of 30.25%, STG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of STG (231.32%) is better than 100.00% of its industry peers.
STG has a Return On Invested Capital of 40.98%. This is amongst the best in the industry. STG outperforms 98.44% of its industry peers.
STG had an Average Return On Invested Capital over the past 3 years of 38.40%. This is significantly above the industry average of 12.02%.
The 3 year average ROIC (38.40%) for STG is below the current ROIC(40.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 30.25%
ROE 231.32%
ROIC 40.98%
ROA(3y)22.33%
ROA(5y)8.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.4%
ROIC(5y)N/A
STG Yearly ROA, ROE, ROICSTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

1.3 Margins

STG has a better Profit Margin (29.67%) than 98.44% of its industry peers.
STG has a better Operating Margin (26.62%) than 96.88% of its industry peers.
Looking at the Gross Margin, with a value of 87.70%, STG belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
STG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.62%
PM (TTM) 29.67%
GM 87.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y1.04%
STG Yearly Profit, Operating, Gross MarginsSTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so STG is creating value.
The number of shares outstanding for STG has been reduced compared to 1 year ago.
Compared to 5 years ago, STG has less shares outstanding
Compared to 1 year ago, STG has an improved debt to assets ratio.
STG Yearly Shares OutstandingSTG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
STG Yearly Total Debt VS Total AssetsSTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

STG has an Altman-Z score of 0.69. This is a bad value and indicates that STG is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of STG (0.69) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.38 indicates that STG is not too dependend on debt financing.
STG has a Debt to Equity ratio (0.38) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACC4.4
WACC9.31%
STG Yearly LT Debt VS Equity VS FCFSTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500M -1B

2.3 Liquidity

STG has a Current Ratio of 1.02. This is a normal value and indicates that STG is financially healthy and should not expect problems in meeting its short term obligations.
STG's Current ratio of 1.02 is on the low side compared to the rest of the industry. STG is outperformed by 62.50% of its industry peers.
A Quick Ratio of 1.02 indicates that STG should not have too much problems paying its short term obligations.
The Quick ratio of STG (1.02) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
STG Yearly Current Assets VS Current LiabilitesSTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

More info and screens

1

3. Growth

3.1 Past

The earnings per share for STG have decreased by -1.02% in the last year.
Looking at the last year, STG shows a decrease in Revenue. The Revenue has decreased by -7.04% in the last year.
Measured over the past years, STG shows a small growth in Revenue. The Revenue has been growing by 1.81% on average per year.
EPS 1Y (TTM)-1.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.68%
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y-0.67%
Revenue growth 5Y1.81%
Sales Q2Q%-4.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STG Yearly Revenue VS EstimatesSTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B
STG Yearly EPS VS EstimatesSTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.96, which indicates a rather cheap valuation of STG.
98.44% of the companies in the same industry are more expensive than STG, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 29.63. STG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.96
Fwd PE N/A
STG Price Earnings VS Forward Price EarningsSTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STG Per share dataSTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

STG has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

STG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLANDS TECHNOLOGY- SP ADR

NYSE:STG (2/21/2025, 8:04:01 PM)

After market: 6.8123 +0.65 (+10.59%)

6.16

-0.43 (-6.53%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)11-22 2024-11-22/bmo
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-9.63%
Ins Owners13.65%
Ins Owner ChangeN/A
Market Cap84.46M
Analysts42.5
Price TargetN/A
Short Float %0.15%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.76
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.96
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 2.21
P/tB 2.22
EV/EBITDA N/A
EPS(TTM)6.42
EY104.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.71
BVpS2.78
TBVpS2.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 30.25%
ROE 231.32%
ROCE 51.88%
ROIC 40.98%
ROICexc 224.38%
ROICexgc 225.46%
OM 26.62%
PM (TTM) 29.67%
GM 87.7%
FCFM N/A
ROA(3y)22.33%
ROA(5y)8.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.4%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)48.6%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.09%
GM growth 5Y1.04%
F-ScoreN/A
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 0.69
F-ScoreN/A
WACC9.31%
ROIC/WACC4.4
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y-0.67%
Revenue growth 5Y1.81%
Sales Q2Q%-4.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A